These findings were consistent with the expression of proinflammatory mediators (e.g., TNF‐α, IL‐1β, IL‐6, and CCL2) typically linked to the progression of insulin resistance in the liver and WAT (Figure 6E,F). Here, IL1B is linked to Insulin resistance.